USE OF PERIPHERAL-BLOOD PROGENITOR CELLS ABROGATES THE MYELOTOXICITY OF REPETITIVE OUTPATIENT HIGH-DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY

TEPLER I CANNISTRA SA FREI E GONIN R ANDERSON KC DEMETRI G NILOFF J GOODMAN H MUNTZ H MUTO M SHEETS E ELIAS AD MAZANET R WHEELER C AYASH L SCHWARTZ G MCCAULEY M GAYNES L HARVEY S SCHNIPPER LE ANTMAN KH

I. Tepler et al., USE OF PERIPHERAL-BLOOD PROGENITOR CELLS ABROGATES THE MYELOTOXICITY OF REPETITIVE OUTPATIENT HIGH-DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY, Journal of clinical oncology, 11(8), 1993, pp. 1583-1591

65

Oncology

Journal of clinical oncology → ACNP

0732183X

11

8

1993

1583 - 1591

ISI

0732-183X(1993)11:8<1583:UOPPCA>2.0.ZU;2-D